GRDN vs HSIC Stock Comparison

Guardian Pharmacy Services and Henry Schein Prices as of Nov 13, 2026 Peers: Industry group
HSIC Henry Schein Inc
$86.22 +0.8% 1M +17.6% 1Y
Market cap
$9.41B
P/E
22.3x
Revenue (TTM)
$13.73B
Div. yield
–
Drug Distribution Healthcare
5 wins

Head to Head

8 decided of 12

Henry Schein leads on 5 of the 12 questions below (Henry Schein 5, Guardian Pharmacy Services 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionGRDNHSICLeader
Larger companyMarket capitalisation $3.12B $9.41B HSIC
Cheaper on earningsLower P/E, profitable companies only 41.7x 22.3x HSIC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 37.5x 14.6x HSIC
Faster revenue growthRevenue growth, trailing twelve months +4.9% +6.2% HSIC
More profitableNet margin, trailing twelve months 5.1% 3.1% GRDN
Better return on capitalReturn on invested capital — 7.3% –
Less leveragedLower net debt / EBITDA — 3.2x –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +62.6% +17.6% GRDN
Better 5-year returnAnnualised price return, 5 years — +1.7%/yr –
Less volatileAnnualised volatility, 1 year 42.4% 25.2% HSIC
Higher overall scoreMean of the five percentile scores vs peers 71/100 57/100 GRDN

Percentile Scorecard

GRDNHSIC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisGRDNHSIC
Valuation 23 #21 of 27 46 #15 of 27
Growth 76 #7 of 26 48 #14 of 26
Profitability 96 #2 of 26 76 #7 of 26
Financial Health 88 #4 of 26 20 #21 of 26
Shareholder Returns – 94 #2 of 18
Overall 71 57
  • GRDN ranked among 27 companies in Healthcare Payers and Distributors
  • HSIC ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodGRDNHSICSPY
1 month +21.9%+0.8% -2.0%
3 months +28.7%-4.0% -2.8%
6 months +35.1%+18.6% +2.0%
Year to date +64.4%+14.1% +10.6%
1 year +62.6%+17.6% +12.2%
3 years —+25.1% +68.1%
3 years, per year —+7.8% +18.9%
5 years —+8.8% +61.4%
5 years, per year —+1.7% +10.1%
10 years —+40.3% +248.5%
10 years, per year —+3.4% +13.3%

Risk

MeasureGRDNHSICSPY
Volatility, 1Y 42.4%25.2% 13.6%
Downside volatility, 1Y 39.1%25.4% 13.9%
Beta vs S&P 500, 1Y 0.710.63 1.00
Return / volatility, 1Y 1.480.70 0.90
Max drawdown, 5Y -27.2%-32.7% -25.4%
From 52-week high -1.1%-5.1% -3.2%
52-week high $50.01$90.86 $779.14
52-week low $27.03$68.99 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleGRDNHSIC
P/E now vs peer median 41.9xmedian 25.2x 22.8xmedian 25.2x
P/S now vs peer median 2.2xmedian 0.4x 0.7xmedian 0.4x
EV/EBITDA now vs peer median 25.6xmedian 14.5x 12.4xmedian 14.5x
P/FCF now vs peer median 40.0xmedian 16.5x 17.0xmedian 16.5x
P/B now vs peer median 11.2xmedian 2.7x 2.5xmedian 2.7x
PEG now vs peer median —median 1.72 6.74median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsGRDNHSIC
Revenue $1.46B $13.73B
Gross profit $327.08M $4.34B
Operating income $94.14M $709.00M
Net income $74.77M $443.00M
Free cash flow $78.35M $559.00M
EPS (diluted) $1.17 $3.74
Cash & equivalents $119.66M $184.00M
Total debt – $3.52B
Shares (diluted) 63.92M 112.54M
Enterprise value $2.78B $9.23B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricGRDNHSIC
P/E 41.9x 22.8x
P/FCF 40.0x 17.0x
P/Operating cash flow 27.5x 13.9x
P/S 2.2x 0.7x
P/B 11.2x 2.5x
P/Tangible book 12.1x 3.3x
EV/EBITDA 25.6x 12.4x
EV/EBIT 32.0x 18.2x
EV/Revenue 2.1x 0.9x
EV/FCF 38.5x 23.0x
EV/Operating cash flow 26.4x 18.7x
PEG (3Y EPS CAGR) – 6.74

Growth

14 metrics
MetricGRDNHSIC
Revenue growth (1Y) 4.9% 6.2%
Revenue CAGR (3Y) – 2.7%
Gross profit growth (1Y) 19.2% 7.5%
Gross profit CAGR (3Y) – 3.3%
Operating income growth (1Y) 60.4% 9.9%
Operating income CAGR (3Y) – 3.0%
Net income growth (1Y) 85.8% 7.5%
Net income CAGR (3Y) – -2.0%
EPS growth (1Y) 84.4% 15.8%
EPS CAGR (3Y) – 3.4%
Operating cash flow growth (1Y) 29.6% 28.4%
Operating cash flow CAGR (3Y) – -4.4%
Free cash flow growth (1Y) 18.9% 38.7%
Free cash flow CAGR (3Y) – -4.9%

Profitability

14 metrics
MetricGRDNHSIC
Gross margin 22.4% 31.6%
EBITDA margin 8.1% 7.6%
Operating margin 6.5% 5.2%
Pretax margin 7.2% 4.2%
Net margin 5.1% 3.1%
FCF margin 5.4% 4.1%
Operating cash flow margin 7.8% 5.0%
Return on equity 28.3% 11.6%
Return on assets 16.3% 3.9%
Return on invested capital – 7.3%
Return on capital employed 32.6% 9.0%
Asset turnover 3.1x 1.2x
Cash conversion (OCF / net income) 1.5x 1.6x
Stock comp / revenue 0.6% 0.3%

Financial Health

11 metrics
MetricGRDNHSIC
Debt / assets – 30.6%
Debt / equity – 0.9x
Net debt / EBITDA – 3.2x
Debt / FCF – 6.3x
Liabilities / assets 43.1% 66.8%
Equity / assets 56.9% 33.2%
Interest coverage 145.3x 4.3x
Current ratio 1.6x 1.3x
Quick ratio 1.3x 0.6x
Cash ratio 0.7x 0.1x
Altman Z-score 13.09 2.65

Shareholder Returns

7 metrics
MetricGRDNHSIC
Dividend yield – –
Net buyback yield – 6.8%
Shareholder yield – 6.8%
Payout ratio (earnings) – 6.8%
Payout ratio (FCF) – 5.4%
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusGRDNHSIC
Forward P/E 37.5xFY2026 14.6xFY2026
EPS, next fiscal year $1.32FY2026 $5.89FY2026
EPS growth, next FY +23.4%FY2026 +18.5%FY2026
EPS growth, the year after +18.9% +5.9%
Revenue, next fiscal year $1.42BFY2026 $13.36BFY2026
Revenue growth, next FY -2.2%FY2026 +1.3%FY2026
Revenue growth, the year after +2.7% +4.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersGRDNHSIC
Held by institutions 58.6% 100.0%
Institutions holding 189 566
Change in shares held, QoQ +3.8% +2.1%
Institutions buying 109 244
Institutions selling 54 217
Buyers to sellers 2.02 1.12

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

GRDNHSIC
GRDN 1.00 0.17
HSIC 0.17 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, GRDN and HSIC?

Henry Schein (HSIC) is the largest by market capitalisation: Guardian Pharmacy Services (GRDN) $3.12B, Henry Schein (HSIC) $9.41B.

Which stock is cheaper, GRDN and HSIC?

Henry Schein (HSIC) trades on the lowest price-to-earnings ratio (Guardian Pharmacy Services (GRDN) 41.7x, Henry Schein (HSIC) 22.3x). On next year's consensus earnings, Henry Schein (HSIC) is cheapest (Guardian Pharmacy Services (GRDN) 37.5x, Henry Schein (HSIC) 14.6x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Henry Schein (HSIC) grew revenue fastest over the trailing twelve months: Guardian Pharmacy Services (GRDN) +4.9%, Henry Schein (HSIC) +6.2%.

Which company is more profitable?

Guardian Pharmacy Services (GRDN) has the highest net margin (Guardian Pharmacy Services (GRDN) 5.1%, Henry Schein (HSIC) 3.1%).

Which stock has performed better?

Over the past year Guardian Pharmacy Services (GRDN) returned the most: Guardian Pharmacy Services (GRDN) +62.6%, Henry Schein (HSIC) +17.6%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Henry Schein (HSIC) has been the steadiest (Guardian Pharmacy Services (GRDN) 42.4%, Henry Schein (HSIC) 25.2%). Volatility measures how widely the price swings, not the risk of the business.

Do GRDN and HSIC move together?

Their daily returns over the past year have a correlation of 0.17, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, GRDN and HSIC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Henry Schein (HSIC) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.